• LOGIN
    Login with username and password
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publications
  • Theses
  • Research Data
  • Projects
  • Organizations
  • Researchers
  • More
  • Collections
  • Statistics
  • LOGIN
    Login with username and password
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. NKX3.1 Localization to Mitochondria Suppresses Prostate Cancer Initiation.

NKX3.1 Localization to Mitochondria Suppresses Prostate Cancer Initiation.

Details
DOI
10.48350/163465
Publisher DOI
10.1158/2159-8290.CD-20-1765
PubMed ID
33893149
Abstract
Mitochondria provide the first line of defense against the tumor-promoting effects of oxidative stress. Here we show that the prostate-specific homeoprotein NKX3.1 suppresses prostate cancer initiation by protecting mitochondria from oxidative stress. Integrating analyses of genetically engineered mouse models, human prostate cancer cells, and human prostate cancer organotypic cultures, we find that, in response to oxidative stress, NKX3.1 is imported to mitochondria via the chaperone protein HSPA9, where it regulates transcription of mitochondrial-encoded electron transport chain (ETC) genes, thereby restoring oxidative phosphorylation and preventing cancer initiation. Germline polymorphisms of NKX3.1 associated with increased cancer risk fail to protect from oxidative stress or suppress tumorigenicity. Low expression levels of NKX3.1 combined with low expression of mitochondrial ETC genes are associated with adverse clinical outcome, whereas high levels of mitochondrial NKX3.1 protein are associated with favorable outcome. This work reveals an extranuclear role for NKX3.1 in suppression of prostate cancer by protecting mitochondrial function. SIGNIFICANCE: Our findings uncover a nonnuclear function for NKX3.1 that is a key mechanism for suppression of prostate cancer. Analyses of the expression levels and subcellular localization of NKX3.1 in patients at risk of cancer progression may improve risk assessment in a precision prevention paradigm, particularly for men undergoing active surveillance.See related commentary by Finch and Baena, p. 2132.This article is highlighted in the In This Issue feature, p. 2113.
Date Issued
2021-09
Publication Type
Article
Subject(s)
500 Science > 570 Life sciences; biology
600 Technology > 610 Medicine & health
Language(s)
en
Author(s)
Papachristodoulou, Alexandros
Rodríguez Calero, José Antonio  
Institut für Pathologie  
Department for BioMedical Research, Forschungsgruppe Präzisionsonkologie  
Panja, Sukanya
Margolskee, Elizabeth
Virk, Renu K
Milner, Teresa A
Martina, Luis Pina
Kim, Jaime Y
Di Bernardo, Matteo
Williams, Alanna B
Maliza, Elvis A
Caputo, Joseph M
Haas, Christopher
Wang, Vinson
De Castro, Guarionex Joel
Wenske, Sven
Hibshoosh, Hanina
McKiernan, James M
Shen, Michael M
Rubin, Mark Andrew  
Department for BioMedical Research, Forschungsgruppe Präzisionsonkologie  
Department for BioMedical Research (DBMR)  
Mitrofanova, Antonina
Dutta, Aditya
Abate-Shen, Cory
Additional Credits
Department for BioMedical Research (DBMR)  
Department for BioMedical Research, Forschungsgruppe Präzisionsonkologie  
Institut für Pathologie  
Journal
Cancer discovery
Publisher
American Association for Cancer Research
ISSN
2159-8290
Access(Rights)
metadata.only
Show full item
BORIS Portal
Bern Open Repository and Information System
Build: 0eaa7c [ 7.08. 11:06]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
  • Audiovisual Material
  • Software & other digital items
  • Events
More
  • About BORIS Portal
  • BORIS Portal & Open Science
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo
Repository logo COAR Notify